UK: +44 1379 658 721
Ireland: +353 89 221 3723
USA: +1 754 252 3536
Middle East - N. Africa: + 971 52 873 4738
Australia: +61 3 9310 5259
In a week when the UK’s foreign secretary Liz Truss tested positive for covid – after speaking to a packed House of Commons without a mask – we’re exploring the latest UK covid news. Read on to find out about Pfizer’s antiviral covid pill, the latest on the BA.2 variant, which is rapidly overtaking Omicron, and more.
The latest covid news in the UK
Thousands of UK citizens will be given Pfizer’s covid antiviral pill from 10th February. Called Paxlovid, it’s designed for high-risk patients, for example those who have cancer or are immunocompromised, and is given when they’ve tested positive for covid. The latest UK covid news on the subject reveals the drug should cut the risk of hospitalisation and death by around 88% in high risk people as long as it’s administered in time.
The BA.2 variant – Latest news and risk assessments
The news about UK covidBA.2 variant? So far the UK has identified over 2500 confirmed cases of BA.2 since 6th Dec. A designated ‘variant under investigation’, the health authorities are keeping a close eye on it. So far they’re not particularly concerned, even though the variant spreads 1.5 times faster than BA.1. On the down side, higher transmissibility may mean we might not see waves of omicron disappear as fast as we hoped. Here’s the latest insight.
BA.2 is a type of omicron, which includes a family of variants that turned up in November last year. The UK, Germany, India and Denmark are seeing a fast-rising percentage of BA.2 as it overtakes BA.1, replacing it in record time.
If you are not vaccinated and haven’t been infected by omicron, you’re at risk. Even if you don’t become very ill with covid, you will play a part in a chain reaction that could easily generate more mutations and more variants.
While it can happen, it looks as though people who have had a recent BA.1 infection won’t easily catch BA.2, especially if they’re vaccinated. If you’ve been vaccinated but haven’t had omicron, it’s good to know the current vaccines are even better at protecting people against BA.2 than they are against the original BA.1. In fact the Health Security Agency says 3 doses gives 70% protection against symptomatic infection.
Will BA.2 cause more waves? Maybe. It will probably prolong current omicron waves in some places. There’s good news from South Africa, whose omicron wave is almost over. They haven’t seen a BA.2 surge even though most new cases are now BA.2. On the other hand if a country hasn’t had an omicron wave, it could easily get a BA.2 wave.
While it’s 50% more transmissible, experts still believe BA.2 is relatively mild. While viruses that are more transmissible can cause more hospitalisations and deaths, simply because they infect so many more people, when there’s a good level of vaccination and immunity, the number and severity of BA.2 infections should remain low.
Lastly, the ‘stealth variant’ label has been dismissed. The variant is in fact easy to pick up using PCR and rapid lateral flow tests.
Covid UK latest news – NHS backlog delayed by omicron
It looks like the plans to tackle NHS England’s backlog of patients has been delayed by omicron, according to Health secretary Sajid Javid. They were planning to originally publish the plan in early December but omicron ‘changed focus’ on to the booster programme. Apparently the plan will be made public ‘soon’, when the omicron wave retreats.
Vaccination means less risk of variants
That was the news about covid in the UK. Finally, a quick warning. The current variants of concern are less dangerous than the originals. But remember, the more of us catch the virus – no matter how mild it is – the more risk there is of variants emerging. And there’s no scientific reason why they shouldn’t be a lot more dangerous than anything we’ve seen so far. That’s viruses for you.
Kill covid stone dead in minutes
Stay safe from covid! Harness affordable, highly effective, clean UVC to kill viruses and their variants stone dead.